An incredible new map could help explain why anger feels similar to fear, and why being in love makes you feel warmhearted.

Scanslated has established scaled partnerships with major healthcare systems, in addition to Longevity Medical Institute, including Duke Health, Northwell Health, and Lumexa Imaging, and is deploying ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Cost: New longevity portfolio includes core MRI for $999, $899 intro offer (about 30 minutes); core MRI plus head and neck ...

The BiPASS trial evaluates Illuccix and Gozellix for prostate cancer detection, aiming to improve diagnostic accuracy and reduce biopsy necessity. Combining MRI with 68Ga-PSMA-11 PET imaging may ...

NOVEL research suggests simple blood-based markers could refine MRI use in prostate cancer detection. Magnetic resonance imaging (MRI) has become central to prostate cancer (PCa) diagnostics, ...

A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant ...